Mr. Rob Gietl reports

MYM APPOINTS HOWARD STEINBERG AS INDEPENDENT DIRECTOR AND VICE-CHAIRMAN OF THE COMPANY

MYM Nutraceuticals Inc. has appointed Howard Steinberg as independent director and vice-chairman of the company, effective Oct. 24, 2018.

Mr. Steinberg has more than 20 years of investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen boards, including his current role as executive chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.

"It is with great excitement that I join the MYM team," said Mr. Steinberg. "Bringing in leadership such as myself is a key step in the transformation process to realize our shared vision of becoming an industry leader. Together, I'm confident we can get there."

"It is an honour to welcome Howard to the MYM team," said Rob Gietl, chief executive officer of MYM. "Howard brings with him a wealth of experience as a senior executive in a variety of businesses. His time spent in global finance and tenure as executive chairman of Parallax have put him in a prime position to help lead MYM to success with our projects around the world."

Mr. Steinberg was granted options to purchase three million common shares of the company in accordance with the company's stock option plan for a period of four years. The options are exercisable at a price of $1.10 per share. Two hundred fifty thousand options will vest in a single tranche immediately; 250,000 options will vest every three months thereafter. Subject to Mr. Steinberg meeting certain targets within the first 12 months of his appointment, the options will vest immediately. The expiry date of these options is Oct. 24, 2022.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals is an innovative company focused on acquiring Health Canada licences to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in a cannabis production project in Australia.

We seek Safe Harbor.